Looking back over the past 12 months, Information Technology was heads and shoulders the best-performing sector.
Avita Medical has announced FDA approval for its new RECELL GO mini disposable cartridge. Spray-on skin The original RECELL platform received FDA approval in 2018 for severe burns ...
Mesoblast specialises in developing medicines that treat severe inflammatory conditions. Their technology is being applied to conditions like chronic heart failure and chronic low back pain.
GenusPlus Group (ASX:GNP) has been awarded a contract, potentially worth $950m, to upgrade Tasmania's North West grid.
Simberi Gold Company, a wholly-owned subsidiary of St Barbara (ASX:SBM), has received a $210m tax assessment from Papua New Guinea’s Internal Revenue Commission.
Paladin Energy (ASX:PDN) has finalised its acquisition of Canadian uranium exploration company Fission Uranium Corp.
FBR (ASX:FBR) has completed its Demonstration Program in Florida, showcasing the capabilities of its Hadrian X robotic technology. The program, conducted in collaboration with CRH Ventures ...
Stocks climbed in the US on Monday as the market kicked off a holiday-shortened trading week, buoyed by strength in technology shares. The S&P 500 rose 0.73% to 5,974.07, while the Nasdaq Composite ...
News Corporation (ASX:NWS) has announced the sale of its 65% stake in Foxtel Group to DAZN Group Ltd for an enterprise value of $3.4bn. Under the terms of the agreement, News Corp will receive ...
Pro Medicus (ASX:PME) has signed a $30m, 7-year contract with Duly Health and Care (DHC), the largest independent multi-specialty physician-directed medical group in the Midwest USA. The agreement ...
Wall Street staged a modest recovery on Friday, closing the week with reduced losses. The S&P 500 rose 1.1%, trimming its weekly loss to 2%, while the Dow added 498 points, or 1.2%, and the Nasdaq ...
EML Payments (ASX:EML) has announced changes in its leadership as part of its commitment to the EML 2.0 strategy. The company has terminated Managing Director and CEO Ron Hynes’ employment ...